Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2016, Article ID 2404857, 10 pages
http://dx.doi.org/10.1155/2016/2404857
Review Article

HIV Infection in the Elderly: Arising Challenges

Department of Internal Medicine, School of Medicine, College of Health Sciences, The University of Dodoma, Dodoma, Tanzania

Received 4 April 2016; Revised 14 June 2016; Accepted 30 June 2016

Academic Editor: Arshad Jahangir

Copyright © 2016 Bonaventura C. T. Mpondo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Mahy, C. S. Autenrieth, K. Stanecki, and S. Wynd, “Increasing trends in HIV prevalence among people aged 50 years and older: evidence from estimates and survey data,” AIDS, vol. 28, supplement 4, pp. S453–S459, 2014. View at Publisher · View at Google Scholar
  2. Centers for Disease Control and Prevention, HIV/AIDS Surveillance Report, CDC, Atlanta, Ga, USA, 2006, http://www.cdc.gov/hiv/topics/surveillance/resources/reports.
  3. J. A. C. Hontelez, S. J. de Vlas, R. Baltussen et al., “The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa,” AIDS, vol. 26, supplement 1, pp. S19–S30, 2012. View at Google Scholar
  4. A. N. Phillips, C. A. Lee, J. Elford et al., “More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts,” Journal of Acquired Immune Deficiency Syndromes, vol. 4, no. 10, pp. 970–975, 1991. View at Google Scholar
  5. U. Balslev, A. D. Monforte, G. Stergiou et al., “Influence of age on rates of new AIDS-defining diseases and survival in 6546 AIDS patients,” Scandinavian Journal of Infectious Diseases, vol. 29, no. 4, pp. 337–343, 1997. View at Publisher · View at Google Scholar
  6. H. Jiang, N. Xie, B. Cao et al., “Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China,” PLoS ONE, vol. 8, no. 12, Article ID e83078, 2013. View at Publisher · View at Google Scholar
  7. F. Bonnet, R. Thiébaut, G. Chêne et al., “Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996–2002,” HIV Medicine, vol. 6, no. 3, pp. 198–205, 2005. View at Publisher · View at Google Scholar
  8. S. Grabar, I. Kousignian, A. Sobel et al., “Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV,” AIDS, vol. 18, no. 15, pp. 2029–2038, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-P. Viard, A. Mocroft, A. Chiesi et al., “Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study,” The Journal of Infectious Diseases, vol. 183, no. 8, pp. 1290–1294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Costagliola, “Demographics of HIV and aging,” Current Opinion in HIV & AIDS, vol. 9, no. 4, pp. 294–301, 2014. View at Publisher · View at Google Scholar
  11. J. Negin and R. G. Cumming, “HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data,” Bulletin of the World Health Organization, vol. 88, no. 11, pp. 847–853, 2010. View at Publisher · View at Google Scholar
  12. E. Eduardo, M. R. Lamb, S. Kandula et al., “Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four Sub-Saharan African countries,” PLoS ONE, vol. 9, no. 7, Article ID e103864, 2014. View at Publisher · View at Google Scholar
  13. Centers for Disease Control and Prevention, “1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults,” Morbidity and Mortality Weekly Report, vol. 41, no. 17, pp. 1–19, 1992. View at Google Scholar
  14. F. J. Palella, K. M. Delaney, A. C. Moorman et al., “Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators,” The New England Journal of Medicine, vol. 338, no. 13, pp. 853–860, 1998. View at Publisher · View at Google Scholar
  15. C. Lewden, T. May, E. Rosenthal et al., “Changes in causes of death among adults infected by HIV between 2000 and 2005: the ‘Mortalité 2000 and 2005’ surveys (ANRS EN19 and Mortavic),” Journal of Acquired Immune Deficiency Syndromes, vol. 48, no. 5, pp. 590–598, 2000. View at Google Scholar
  16. K. A. Mack and M. G. Ory, “AIDS and older Americans at the end of the twentieth century,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, supplement 2, pp. S68–S75, 2016. View at Google Scholar
  17. D. Zablotsky and M. Kennedy, “Risk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practices,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, supplement 2, pp. S122–S130, 2003. View at Google Scholar
  18. G. Orlando, P. Meraviglia, L. Cordier et al., “Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients,” HIV Medicine, vol. 7, no. 8, pp. 549–557, 2006. View at Publisher · View at Google Scholar
  19. S. Mensforth, L. Goodall, N. Bodasing, and J. Coultas, “Late diagnosis among our ageing HIV population: a cohort study,” Journal of the International AIDS Society, vol. 17, no. 4, supplement 3, Article ID 19692, 2014. View at Google Scholar
  20. S. Grabar, L. Weiss, and D. Costagliola, “HIV infection in older patients in the HAART era,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 1, pp. 4–7, 2006. View at Publisher · View at Google Scholar
  21. R. C. Kalayjian, A. Landay, R. B. Pollard et al., “Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes,” The Journal of Infectious Diseases, vol. 187, no. 12, pp. 1924–1933, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Naylor, G. Li, A. N. Vallejo et al., “The influence of age on T cell generation and TCR diversity,” The Journal of Immunology, vol. 174, no. 11, pp. 7446–7452, 2005. View at Publisher · View at Google Scholar
  23. R. B. Effros, “T cell replicative senescence: pleiotropic effects on human aging,” Annals of the New York Academy of Sciences, vol. 1019, pp. 123–126, 2004. View at Google Scholar
  24. D. C. Douek, M. R. Betts, B. J. Hill et al., “Evidence for increased T cell turnover and decreased thymic output in HIV infection,” Journal of Immunology, vol. 167, no. 11, pp. 6663–6668, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Egger, M. May, G. Chêne et al., “Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies,” The Lancet, vol. 360, no. 9327, pp. 119–129, 2002. View at Publisher · View at Google Scholar
  26. K. Titanji, F. Chiodi, R. Bellocco et al., “Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions,” AIDS, vol. 19, no. 17, pp. 1947–1955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. De Milito, C. Mörch, A. Anders Sönnerborg, and F. Chiodi, “Loss of memory (CD27) B lymphocytes in HIV-1 infection,” AIDS, vol. 15, no. 8, pp. 957–964, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. H. C. Lane, H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci, “Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome,” The New England Journal of Medicine, vol. 309, no. 8, pp. 453–458, 1983. View at Publisher · View at Google Scholar
  29. P. J. Linton and K. Dorshkind, “Age-related changes in lymphocyte development and function,” Nature Immunology, vol. 5, pp. 133–139, 2004. View at Publisher · View at Google Scholar
  30. L. A. Jackson, K. M. Neuzil, O. Yu et al., “Effectiveness of pneumococcal polysaccharide vaccine in older adults,” The New England Journal of Medicine, vol. 348, no. 18, pp. 1747–1755, 2003. View at Google Scholar
  31. R. Manfredi and F. Chiodo, “A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age,” AIDS, vol. 14, no. 10, pp. 1475–1477, 2000. View at Publisher · View at Google Scholar
  32. D. C. Douek, R. D. McFarland, P. H. Keiser et al., “Changes in thymic function with age and during the treatment of HIV infection,” Nature, vol. 396, no. 6712, pp. 690–695, 1998. View at Publisher · View at Google Scholar
  33. B. F. Haynes, M. L. Markert, G. D. Sempowski, D. D. Patel, and L. P. Hale, “The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection,” Annual Review of Immunology, vol. 18, pp. 529–560, 2000. View at Publisher · View at Google Scholar
  34. A. L. Gruver, L. I. Hudson, and G. D. Sempowski, “Immunosenescence of ageing,” The Journal of Pathology, vol. 211, no. 2, pp. 144–156, 2007. View at Publisher · View at Google Scholar
  35. G. R. Kaufmann, H. Furrer, B. Ledergerber et al., “Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/μL in HIV type 1—infected individuals receiving potent antiretroviral therapy,” Clinical Infectious Diseases, vol. 41, no. 3, pp. 361–372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Cuzin, C. Delpierre, S. Gerard, P. Massip, and B. Marchou, “Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years,” Clinical Infectious Diseases, vol. 45, no. 5, pp. 654–657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Tumbarello, R. Rabagliati, K. de Gaetano Donati et al., “Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy,” BMC Infectious Diseases, vol. 4, article 46, 2004. View at Google Scholar
  38. B. C. T. Mpondo, D. W. Gunda, S. B. Kilonzo, and E. Mgina, “Immunological and clinical responses following the use of antiretroviral therapy among elderly HIV-infected individuals attending care and treatment clinic in Northwestern Tanzania: a retrospective cohort study,” Journal of Sexually Transmitted Diseases, vol. 2016, Article ID 5235269, 4 pages, 2016. View at Publisher · View at Google Scholar
  39. K. Goodkin, P. Shapshak, D. Asthana et al., “Older age and plasma viral load in HIV-1 infection,” AIDS, vol. 18, supplement 1, pp. S87–S98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Manfredi, L. Calza, D. Cocchi, and F. Chiodo, “Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 1, pp. 112–114, 2003. View at Publisher · View at Google Scholar
  41. M. Tumbarello, R. Rabagliati, K. De Gaetano Donati et al., “Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario,” AIDS, vol. 17, no. 1, pp. 128–131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. C. A. Sabin, C. J. Smith, A. d'Arminio Monforte et al., “Response to combination antiretroviral therapy: variation by age,” AIDS, vol. 22, no. 12, pp. 1463–1473, 2008. View at Publisher · View at Google Scholar
  43. A. H. Greenbaum, L. E. Wilson, J. C. Keruly, R. D. Moore, and K. A. Gebo, “Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals,” AIDS, vol. 22, no. 17, pp. 2331–2339, 2008. View at Publisher · View at Google Scholar
  44. A. S. Semeere, I. Lwanga, J. Sempa et al., “Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, Uganda,” Journal of Acquired Immune Deficiency Syndromes, vol. 67, no. 4, pp. 382–389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. P. C. Mutevedzi, R. J. Lessells, A. J. Rodger, M. Newell, and L. Myer, “Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults,” PLoS ONE, vol. 6, no. 7, Article ID e21795, 2011. View at Publisher · View at Google Scholar
  46. M. Maskew, A. T. Brennan, A. P. MacPhail, I. M. Sanne, and M. P. Fox, “Poorer ART outcomes with increasing age at a large public sector HIV clinic in Johannesburg, South Africa,” Journal of the International Association of Providers of AIDS Care, vol. 11, no. 1, pp. 57–65, 2012. View at Publisher · View at Google Scholar
  47. M. S. Rhee and D. J. Greenblatt, “Pharmacologic consideration for the use of antiretroviral agents in the elderly,” Journal of Clinical Pharmacology, vol. 48, no. 10, pp. 1212–1225, 2008. View at Publisher · View at Google Scholar
  48. R. Bressler and J. J. Bahl, “Principles of drug therapy for the elderly patient,” Mayo Clinic Proceedings, vol. 78, no. 12, pp. 1564–1577, 2003. View at Publisher · View at Google Scholar
  49. A. A. Mangoni and S. H. D. Jackson, “Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications,” British Journal of Clinical Pharmacology, vol. 57, no. 1, pp. 6–14, 2004. View at Publisher · View at Google Scholar
  50. M. Goicoechea, S. Liu, B. Best et al., “Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy,” The Journal of Infectious Diseases, vol. 197, no. 1, pp. 102–108, 2008. View at Publisher · View at Google Scholar
  51. A. O. Ogedegbe and M. S. Sulkowski, “Antiretroviral-associated liver injury,” Clinical Liver Disease, vol. 7, no. 2, pp. 475–499, 2003. View at Google Scholar
  52. R. Bhatia, P. Ryscavage, and B. Taiwo, “Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy,” Journal of NeuroVirology, vol. 18, no. 4, pp. 247–255, 2012. View at Publisher · View at Google Scholar
  53. K. Meir-Shafrir and S. Pollack, “Accelerated aging in HIV patients,” Rambam Maimonides Medical Journal, vol. 3, no. 4, Article ID e0025, 2012. View at Publisher · View at Google Scholar
  54. G. Guaraldi, G. Orlando, S. Zona et al., “Premature age-related comorbidities among HIV-infected persons compared with the general population,” Clinical Infectious Diseases, vol. 53, no. 11, pp. 1120–1126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM), “Fat distribution in women with HIV infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 42, no. 5, pp. 562–571, 2006. View at Publisher · View at Google Scholar
  56. P. Bacchetti, B. Gripshover, C. Grunfeld et al., “Fat distribution in men with HIV infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 40, no. 2, pp. 121–131, 2005. View at Publisher · View at Google Scholar
  57. D. Nolan and S. Mallal, “The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome,” Journal of HIV Therapy, vol. 9, no. 2, pp. 34–40, 2004. View at Google Scholar
  58. E. Martínez, A. Mocroft, M. A. García-Viejo et al., “Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study,” The Lancet, vol. 357, no. 9256, pp. 592–598, 2001. View at Publisher · View at Google Scholar
  59. S. A. Riddler, E. Smit, S. R. Cole et al., “Impact of HIV infection and HAART on serum lipids in men,” Journal of the American Medical Association, vol. 289, no. 22, pp. 2978–2982, 2003. View at Google Scholar
  60. S. C. Smith, R. Jackson, T. A. Pearson et al., “Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum,” Circulation, vol. 109, no. 25, pp. 3112–3121, 2004. View at Google Scholar
  61. S. D. Holmberg, A. C. Moorman, J. M. Williamson et al., “Protease inhibitors and cardiovascular outcomes in patients with HIV-1,” The Lancet, vol. 360, no. 9347, pp. 1747–1748, 2002. View at Publisher · View at Google Scholar
  62. S. D. Holmberg, A. C. Moorman, and A. E. Greenberg, “Trends in rates of myocardial infarction among patients with HIV,” The New England Journal of Medicine, vol. 350, no. 7, pp. 370–372, 2004. View at Google Scholar
  63. P. M. Coplan, A. Nikas, A. Japour et al., “Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors,” AIDS Research and Human Retroviruses, vol. 19, no. 6, pp. 449–455, 2003. View at Publisher · View at Google Scholar
  64. S. A. Bozzette, C. F. Ake, H. K. Tam, S. W. Chang, and T. A. Louis, “Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection,” The New England Journal of Medicine, vol. 348, pp. 702–710, 2003. View at Google Scholar
  65. R. Palacios Muñoz, J. Santos, A. García et al., “Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients,” HIV Medicine, vol. 7, no. 1, pp. 10–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. C. M. Wyatt, J. A. Winston, C. D. Malvestutto et al., “Chronic kidney disease in HIV infection: an urban epidemic,” AIDS, vol. 21, no. 15, pp. 2101–2103, 2007. View at Publisher · View at Google Scholar
  67. A. Mocroft, O. Kirk, J. Gatell et al., “Chronic renal failure among HIV-1-infected patients,” AIDS, vol. 21, no. 9, pp. 1119–1127, 2007. View at Publisher · View at Google Scholar
  68. G. M. Lucas, S. H. Mehta, M. G. Atta et al., “End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004,” AIDS, vol. 21, no. 18, pp. 2435–2443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Tajiri and Y. Shimizu, “Liver physiology and liver diseases in the elderly,” World Journal of Gastroenterology, vol. 19, no. 46, pp. 8459–8467, 2013. View at Publisher · View at Google Scholar
  70. A. Risbud, S. Mehendale, S. Basu et al., “Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India,” Sexually Transmitted Infections, vol. 78, no. 3, pp. 169–173, 2002. View at Publisher · View at Google Scholar
  71. C. J. Uneke, O. Ogbu, P. U. Inyama, G. I. Anyanwu, M. O. Njoku, and J. H. Idoko, “Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria,” Memórias do Instituto Oswaldo Cruz, vol. 100, no. 1, pp. 13–16, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Platt, P. Easterbrook, E. Gower et al., “Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 16, no. 7, pp. 797–808, 2016. View at Publisher · View at Google Scholar
  73. R. Weber, C. A. Sabin, N. Friis-Møller et al., “Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study,” Archives of Internal Medicine, vol. 166, no. 15, pp. 1632–1641, 2006. View at Publisher · View at Google Scholar
  74. D. L. Schmucker, “Age-related changes in liver structure and function: implications for disease?” Experimental Gerontology, vol. 40, no. 8-9, pp. 650–659, 2005. View at Publisher · View at Google Scholar
  75. J. J. Goedert, M. E. Eyster, M. M. Lederman et al., “End-stage liver disease in persons with hemophilia and transfusion-associated infections,” Blood, vol. 100, no. 5, pp. 1584–1589, 2002. View at Google Scholar
  76. D. Posthouwer, M. Makris, T. T. Yee et al., “Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study,” Blood, vol. 109, no. 9, pp. 3667–3671, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. R. Bedimo, R. Y. Chen, N. A. Accortt et al., “Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989–2002,” Clinical Infectious Diseases, vol. 39, no. 9, pp. 1380–1384, 2004. View at Google Scholar
  78. R. J. Bedimo, K. A. McGinnis, M. Dunlap, M. C. Rodriguez-Barradas, and A. C. Justice, “Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART Era: impact of immunosuppression,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 2, pp. 203–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. G. M. Clifford, J. Polesel, M. Rickenbach et al., “Cancer risk in the swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy,” JNCI Journal of the National Cancer Institute, vol. 97, no. 6, pp. 425–432, 2005. View at Publisher · View at Google Scholar
  80. E. A. Engels and J. J. Goedert, “Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future,” JNCI Journal of the National Cancer Institute, vol. 97, no. 6, pp. 407–409, 2005. View at Publisher · View at Google Scholar
  81. N. Crum-Cianflone, K. H. Hullsiek, V. Marconi et al., “Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study,” AIDS, vol. 23, no. 1, pp. 41–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. C. C. Watkins and G. J. Treisman, “Cognitive impairment in patients with AIDS—prevalence and severity,” HIV/AIDS, vol. 7, pp. 35–47, 2015. View at Google Scholar
  83. B. M. Ances and R. J. Ellis, “Dementia and neurocognitive disorders due to HIV-1 infection,” Seminars in Neurology, vol. 27, no. 1, pp. 86–92, 2007. View at Publisher · View at Google Scholar
  84. R. K. Heaton, I. Grant, N. Butters et al., “The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center,” Journal of the International Neuropsychological Society, vol. 1, no. 3, pp. 231–251, 1995. View at Google Scholar
  85. R. K. Heaton, T. D. Marcotte, M. R. Mindt et al., “The impact of HIV-associated neuropsychological impairment on everyday functioning,” Journal of the International Neuropsychological Society, vol. 10, no. 3, pp. 317–331, 2004. View at Google Scholar
  86. V. Valcour, C. Shikuma, B. Shiramizu et al., “Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 Cohort,” Neurology, vol. 63, no. 5, pp. 822–827, 2004. View at Publisher · View at Google Scholar
  87. N. Sacktor, M. P. McDermott, K. Marder et al., “HIV-associated cognitive impairment before and after the advent of combination therapy,” Journal of Neurovirology, vol. 8, no. 2, pp. 136–142, 2002. View at Publisher · View at Google Scholar
  88. B. Hasse, B. Ledergerber, H. Furrer et al., “Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study,” Clinical Infectious Diseases, vol. 53, no. 11, pp. 1130–1139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Holtzman, C. Armon, E. Tedaldi et al., “Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population,” Journal of General Internal Medicine, vol. 28, no. 10, pp. 1302–1310, 2013. View at Publisher · View at Google Scholar
  90. C. Marzolini, L. Elzi, S. Gibbons et al., “Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort study,” Antiviral Therapy, vol. 15, no. 3, pp. 413–423, 2010. View at Publisher · View at Google Scholar
  91. A. Tseng, L. Szadkowski, S. Walmsley, I. Salit, and J. Raboud, “Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients,” Annals of Pharmacotherapy, vol. 47, no. 11, pp. 1429–1439, 2013. View at Publisher · View at Google Scholar
  92. L. J. Gleason, A. E. Luque, and K. Shah, “Polypharmacy in the HIV-infected older adult population,” Journal of Clinical Interventions in Aging, vol. 8, pp. 749–763, 2013. View at Publisher · View at Google Scholar
  93. E. J. Edelman, K. S. Gordon, J. Glover, I. R. McNicholl, D. A. Fiellin, and A. C. Justice, “The next therapeutic challenge in HIV: polypharmacy,” Drugs & Aging, vol. 30, no. 8, pp. 613–628, 2013. View at Publisher · View at Google Scholar
  94. E. R. Hajjar, A. C. Cafiero, and J. T. Hanlon, “Polypharmacy in elderly patients,” The American Journal of Geriatric Pharmacotherapy, vol. 5, no. 4, pp. 345–351, 2007. View at Publisher · View at Google Scholar
  95. R. E. Pel-Littel, M. J. Schuurmans, M. H. Emmelot-Vonk, and H. J. Verhaar, “Frailty: defining and measuring of a concept,” The Journal of Nutrition, Health and Aging, vol. 13, no. 4, pp. 390–394, 2009. View at Publisher · View at Google Scholar
  96. L. P. Fried, Q.-L. Xue, A. R. Cappola et al., “Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 64, no. 10, pp. 1049–1057, 2009. View at Publisher · View at Google Scholar
  97. L. P. Fried, C. M. Tangen, J. Walston et al., “Frailty in older adults: evidence for a phenotype,” Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 56, no. 3, pp. M146–M156, 2001. View at Google Scholar
  98. L. P. Fried, L. Ferrucci, J. Darer, J. D. Williamson, and G. Anderson, “Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care,” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 59, no. 3, pp. 255–263, 2004. View at Publisher · View at Google Scholar
  99. N. F. Önen and E. T. Overton, “A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging,” Current Aging Science, vol. 4, no. 1, pp. 33–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Pathai, C. Gilbert, H. A. Weiss, C. Cook, R. Wood, L.-G. Bekker et al., “Frailty in HIV-infected adults in South Africa,” JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 62, no. 1, pp. 43–51, 2013. View at Publisher · View at Google Scholar
  101. N. F. Onen, A. Agbebi, E. Shacham, K. E. Stamm, A. R. Onen, and E. T. Overton, “Frailty among HIV-infected persons in an urban outpatient care setting,” The Journal of Infection, vol. 59, no. 5, pp. 346–352, 2009. View at Publisher · View at Google Scholar
  102. U. Sandkovsky, K. R. Robertson, J. L. Meza et al., “Pilot study of younger and older HIV-infected adults using traditional and novel functional assessments,” HIV Clinical Trials, vol. 14, no. 4, pp. 165–174, 2014. View at Publisher · View at Google Scholar
  103. K. K. Oursler, J. D. Sorkin, B. A. Smith, and L. I. Katzel, “Reduced aerobic capacity and physical functioning in older HIV-infected men,” AIDS Research and Human Retroviruses, vol. 22, no. 11, pp. 1113–1121, 2006. View at Publisher · View at Google Scholar
  104. K. K. Oursler, J. L. Goulet, S. Crystal et al., “Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study,” AIDS Patient Care and STDs, vol. 25, no. 1, pp. 13–20, 2011. View at Publisher · View at Google Scholar
  105. D. L. Stanton, A. W. Wu, R. D. Moore et al., “Functional status of persons with HIV infection in an ambulatory setting,” Journal of Acquired Immune Deficiency Syndromes, vol. 7, no. 10, pp. 1050–1056, 1994. View at Google Scholar
  106. R. Harding, C. Clucas, F. C. Lampe et al., “What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factors,” AIDS Care, vol. 24, no. 8, pp. 963–971, 2012. View at Publisher · View at Google Scholar
  107. J. S. Merlin, A. O. Westfall, E. Chamot et al., “Pain is independently associated with impaired physical function in HIV-infected patients,” Pain Medicine, vol. 14, no. 12, pp. 1985–1993, 2013. View at Publisher · View at Google Scholar
  108. E. E. Morgan, J. E. Iudicello, E. Weber et al., “Synergistic effects of HIV infection and older age on daily functioning,” Journal of Acquired Immune Deficiency Syndromes, vol. 61, no. 3, pp. 341–348, 2012. View at Publisher · View at Google Scholar
  109. UNAIDS, “Global HIV/AIDS epidemic,” Fact Sheet 2015, 2015. View at Google Scholar
  110. J. A. C. Hontelez, M. N. Lurie, M.-L. Newell et al., “Ageing with HIV in South Africa,” AIDS, vol. 25, no. 13, pp. 1665–1667, 2011. View at Publisher · View at Google Scholar
  111. J. Negin, T. Bärnighausen, J. D. Lundgren, and E. J. Mills, “Aging with HIV in Africa,” AIDS, vol. 26, pp. S1–S5, 2012. View at Publisher · View at Google Scholar
  112. T. Bärnighausen, T. Welz, V. Hosegood et al., “Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa,” Journal of Human Hypertension, vol. 22, no. 3, pp. 236–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. S. Dalal, J. J. Beunza, J. Volmink et al., “Non-communicable diseases in sub-Saharan Africa: what we know now,” International Journal of Epidemiology, vol. 40, no. 4, pp. 885–901, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Thorogood, M. Connor, S. Tollman, G. Lewando Hundt, G. Fowkes, and J. Marsh, “A cross-sectional study of vascular risk factors in a rural South African population: data from the Southern African Stroke Prevention Initiative (SASPI),” BMC Public Health, vol. 7, article 326, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Negin, A. Martiniuk, R. G. Cumming et al., “Prevalence of HIV and chronic comorbidities among older adults,” AIDS, vol. 26, supplement 1, pp. S55–S63, 2012. View at Publisher · View at Google Scholar
  116. G. Fatti, E. Mothibi, G. Meintjes, A. Grimwood, and R. V. Barnabas, “Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa,” PLoS ONE, vol. 9, no. 6, article e100273, 2014. View at Publisher · View at Google Scholar
  117. R. W. Kimokoti and D. H. Hamer, “Nutrition, health, and aging in sub-Saharan Africa,” Nutrition Reviews, vol. 66, pp. 611–623, 2008. View at Google Scholar
  118. J. Greig, E. C. Casas, D. P. O'Brien, E. J. Mills, and N. Ford, “Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries,” AIDS, vol. 26, supplement 1, pp. S31–S37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. K. P. High, M. Brennan-Ing, D. B. Clifford et al., “HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group,” Journal of Acquired Immune Deficiency Syndromes, vol. 60, supplement 1, pp. S1–S18, 2012. View at Publisher · View at Google Scholar